Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Cytokine Panel 1 (human) Kit includes ten biomarkers that are associated with the inflammatory response and immune system regulation (Table 1). The assays can be used for quantitative measurements in the sample types listed in the “Specifications” tab below and offer detection limits (LLODs and LLOQs) in the sub- to low pg/mL range.
V-PLEX Plus kits include controls, wash buffer, and plate seals.
| Analyte | LLOD | LLOQ | ULOQ | Dynamic Range | Unit | | GM-CSF | 0.16 | 0.842 | 750 | 0.16 - 750 | pg/mL |
| IL-1α | 0.09 | 2.85 | 278 | 0.09 - 278 | pg/mL |
| IL-5 | 0.14 | 4.41 | 562 | 0.14 - 562 | pg/mL |
| IL-7 | 0.12 | 0.851 | 563 | 0.12 - 563 | pg/mL |
| IL-12/IL-23p40 | 0.33 | 1.32 | 2,250 | 0.33 - 2,250 | pg/mL |
| IL-15 | 0.15 | 0.774 | 525 | 0.15 - 525 | pg/mL |
| IL-16 | 2.83 | 19.1 | 1,870 | 2.83 - 1,870 | pg/mL |
| IL-17A | 0.31 | 3.19 | 3,650 | 0.31 - 3,650 | pg/mL |
| TNF-β | 0.08 | 0.465 | 458 | 0.08 - 458 | pg/mL |
| VEGF-A | 1.12 | 7.7 | 562 | 1.12 - 562 | pg/mL |
|
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF-A
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Urine, Cell Culture Supernatant
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Cytokine Panel 1 Human Control 1
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 2
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 3
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Diluent Assembly 3 (includes Diluent 3 - 5 mL, and Diluent 43 - 10 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Cytokine Panel 1 Human Control 1
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 2
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 3
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Diluent Assembly 4 (includes Diluent 3 - 25 mL, and Diluent 43 - 50 mL)
|
≤-10 °C
|
1 each
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Cytokine Panel 1 Human Control 1
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 2
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
Cytokine Panel 1 Human Control 3
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Cytokine Panel 1 (human) Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Diluent Assembly 4 (includes Diluent 3 - 25 mL, and Diluent 43 - 50 mL)
|
≤-10 °C
|
5 each
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity
|
|
|
|
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters